Pioglitazone and bladder cancer: a propensity score matched cohort study

Li Wei, Thomas M. MacDonald, Isla S. Mackenzie
2012 British Journal of Clinical Pharmacology  
CONCLUSION The results suggest that pioglitazone may not be significantly associated with an increased risk of bladder cancer in patients with type 2 diabetes. Pioglitazone and bladder cancer Br J Clin Pharmacol / 75:1 / 257
doi:10.1111/j.1365-2125.2012.04325.x pmid:22574756 pmcid:PMC3555065 fatcat:imqhqmakq5aqdow6xknnfuaoti